Bayesian Interpretation of the EXCEL Trial and Other Randomized Clinical Trials of Left Main Coronary Artery Revascularization
Author:
Affiliation:
1. McGill University Health Center, Montreal, Quebec, Canada
Publisher
American Medical Association (AMA)
Subject
Internal Medicine
Link
https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2766594/jamainternal_brophy_2020_oi_200027.pdf
Reference24 articles.
1. The VA cooperative randomized study of surgery for coronary arterial occlusive disease II: subgroup with significant left main lesions.;Takaro;Circulation,1976
2. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.;Serruys;N Engl J Med,2009
3. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.;Mohr;Lancet,2013
4. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.;Thuijs;Lancet,2019
5. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery trial.;Morice;Circulation,2014
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Developments in the Design, Conduct, and Reporting of Child Health Trials;Pediatrics;2024-06-04
2. A comparison of computational algorithms for the Bayesian analysis of clinical trials;Clinical Trials;2024-05-16
3. Left main coronary artery disease: percutaneous coronary intervention or coronary artery bypass grafting? A critical review of current knowledge and contemporary debates;Polish Journal of Cardio-Thoracic Surgery;2024
4. Efficacy of Colchicine in Coronary Disease: Bayesian Analysis and Null-Hypothesis Testing;2024
5. Quantifying the benefit of nonselective beta-blockers in the prevention of hepatic decompensation: A Bayesian reanalysis of the PREDESCI trial;Hepatology;2023-03-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3